Alternatives schedules against hepatitis b in homeless person in Goias

Randomized clinical trial of alternatives schedules against hepatitis b and serum epidemiological study of syphilis and caused infections human immunodeficiency virus and viral hepatitis in homeless person in Goias

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-6ffdnx

Enrollment

Unknown

Registered

2018-05-21

Start date

2018-03-05

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic viral hepatitis B without delta-agent

Interventions

The present study proposes to evaluate the immunogenicity of the recombinant GeneVac-B vaccine, against hepatitis B, administered in the ultra-accelerated and accelerated schedules. Homeless men susce

Biological/vaccine

D20.215.894.899.955.400

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Man aged 18 years or over; who have lived in a street situation for at least 30 days; who are in the place of data collection for a maximum of 30 consecutive days and who are susceptible to the hepatitis B virus.

Exclusion criteria

Exclusion criteria: Man with confirmed serological diagnosis of HIV; with some contraindication of the vaccine.

Design outcomes

Primary

Measure	Time frame
After completing the three doses of the vaccination schedule, to present seroprotection against hepatitis B, considering titers of anti-HBs greater than or equal to 10 IU / L.	—

Secondary

Measure	Time frame
To identify which of the vaccination schedules performed presented greater adherence, considering the conclusion of the three doses in each schedule.	—

Countries

Brazil

Contacts

Public ContactSandra Maria Souza

Faculdade de Enfermagem Universidade Federal de Goiás

sandrabrunini@hotmail.com+55-62-981133290

Outcome results

None listed

Source: REBEC (via WHO ICTRP)